English
French
Portuguese
Spanish
Neurodegenerative disorders, including Alzheimer’s disease and Parkinson’s disease, are characterized by progressive cognitive decline, and global efforts are underway to develop effective treatments. Key proteins such as β-amyloid are implicated in the pathogenesis of these diseases.
This poster demonstrates the evaluation of the performance of ionic liquids as inhibitors of amyloid aggregate formation and as solubilizers of β-amyloid peptide aggregates using CD spectroscopy and the BeStSel program, which allows accurate and detailed evaluation of secondary structure of proteins.